By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vericel (Formerly Known As Aastrom Biosciences, Inc.) 

64 Sidney Sreet
P.O. Box 376
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-588-5555 Fax: 617-588-5554



Company News
Vericel (ASTM)'s Stem Cell Heart Failure Therapy Cuts Deaths 4/5/2016 6:28:41 AM
Vericel (ASTM) Announces Publication Of Clinical Trial Rationale And Study Design For The Phase IIb Ixcell-DCM Trial Of Ixmyelocel-T In Patients With Heart Failure Due To Ischemic Dilated Cardiomyopathy 3/28/2016 7:44:29 AM
Vericel (ASTM) Reports Fourth-Quarter And Year-End 2015 Financial Results 3/14/2016 7:44:10 AM
Vericel (ASTM) Stock Jumps 80% as Heart Drug Meets Main Goal in Phase II Study 3/10/2016 7:54:24 AM
Vericel (ASTM) To Present At 28th Annual ROTH Conference 3/9/2016 8:12:10 AM
Vericel (ASTM) Enters Into $10 Million Credit Facility And $5 Million Term Loan Agreement With Silicon Valley Bank 3/9/2016 7:19:04 AM
Vericel (ASTM) Announces FDA Acceptance For Filing Of BLA For MACI For The Treatment Of Symptomatic Cartilage Defects In The Knee 3/7/2016 8:21:04 AM
Vericel (ASTM) To Host Fourth-Quarter 2015 Earnings Webcast And Conference Call On March 14, 2016 2/29/2016 8:13:23 AM
Vericel (ASTM) To Present At Canaccord Genuity Investor Conference 2/25/2016 10:15:52 AM
Vericel (ASTM) Announces FDA Approval Of Epicel HDE Supplement 2/22/2016 8:32:13 AM